Tempus AI
VP of Product - Oncology – Somatic Tissue
The Vice President of Product, Oncology – Somatic Tissue Diagnostics, leads the strategic direction, execution, and innovation of the somatic tissue diagnostic portfolio. This role manages the entire product lifecycle, from ideation and R&D coordination to commercial launch and P&L management, focusing on advanced NGS-based assays and multiomic platforms to improve cancer care outcomes.
Key Responsibilities
- • Develop and manage a comprehensive product roadmap for the oncology somatic tissue diagnostics portfolio, integrating customer feedback, technology advancements, and clinical oncology trends to address unmet needs in cancer diagnostics.
- • Lead in-depth market research and competitive analyses against industry leaders in oncology diagnostics to identify portfolio gaps, emerging opportunities, and potential differentiators.
- • Oversee upstream Product Managers in end-to-end lifecycle management for somatic tissue molecular testing services, ensuring successful launches and continuous enhancements of assays and platforms tailored for oncology applications.
- • Drive product positioning, messaging, and go-to-market (GTM) strategies for oncology diagnostics by guiding downstream Marketing Managers and collaborating closely with sales, market access, and medical affairs teams to maximize adoption and clinical impact.
- • Maintain full accountability for the oncology product portfolio P&L, focusing on revenue growth, resource allocation, and measurable business outcomes.
- • Build strong relationships with key opinion leaders, oncologists, pathologists, and patient advocacy groups to inform product strategy and support clinical adoption.
- • Ensure product development and commercialization meet all regulatory requirements for oncology diagnostics, including FDA, CLIA, CAP, and international standards.
Required
- • Ability to develop and communicate a compelling value proposition that demonstrates the clinical and economic benefits of oncology diagnostics to payers, providers, and health systems.
- • Expertise in navigating complex reimbursement landscapes and designing creative pricing or risk-sharing models for cancer testing.
- • Specialized capability to integrate the patient journey and voice into product design and commercial strategy, including engagement with oncology patient advocacy groups to address barriers such as access, cost, and equity.
- • Proficiency in leveraging advanced data science and AI models to identify clinical gaps, optimize test utilization, and forecast adoption obstacles in oncology diagnostics.
- • Ability to influence and lead multidisciplinary teams—including R&D, Medical Affairs, Regulatory, and Sales—without direct authority, harmonizing these groups to ensure products remain clinically relevant and commercially successful.
- • High-level ability to make critical, data-informed decisions under pressure in the rapidly evolving oncology diagnostics landscape, including strategic agility to pivot the product roadmap in response to new clinical discoveries or regulatory changes.
- • Strong understanding of regulatory pathways and quality standards for oncology diagnostics, including FDA submissions, CLIA validation, and CAP accreditation.
- • Bachelor’s degree in Biology, Genetics, Oncology, or a related scientific field.
- • Deep understanding of oncology, including somatic mutation biology, cancer genomics, clinical workflows, and the evolving landscape of tissue diagnostics.
- • Extensive knowledge of market demands, technology trends, and the regulatory environment for oncology molecular diagnostics.
Preferred
- • Advanced degree such as an MBA, PhD, or MD is highly preferred, bridging the gap between complex science, clinical oncology, and business strategy.
- • Minimum of 10+ years of progressive leadership experience in product management, specifically within oncology diagnostics, molecular pathology, or genetics-based healthcare.
- • Proven track record of developing complex portfolio plans and leading successful commercial launches of oncology diagnostic tests at scale in a competitive market.
- • Significant experience navigating the unique challenges of the oncology diagnostics market, including specialized billing practices, regulatory pathways, and patient-centric programs.
Benefits & Perks
- • Incentive compensation
- • Restricted stock units
- • Medical and other benefits depending on the position
Company Overview
Industry: Healthcare Technology
Company Size: 500-1,000 employees
Founded: 2015
Headquarters: San Francisco, CA
Company Links
Key Contacts
Contact information not available
About the Company
Leading healthcare technology company focused on improving patient outcomes through innovative digital solutions. We're transforming the way healthcare is delivered with cutting-edge technology and data-driven insights. Our platform serves over 10,000 healthcare professionals and has processed millions of patient interactions.
Recent News & Updates
Series B
Raised $50M Series B funding - Jan 2024
Award
Named "Best Healthcare Startup" by TechCrunch - Dec 2023
Growth
Expanded to 5 new states - Nov 2023
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
The Vice President of Product, Oncology – Somatic Tissue Diagnostics, is a visionary executive responsible for setting the strategic direction, execution, and innovation of the company’s somatic tissue diagnostic portfolio. This role oversees the entire product lifecycle—from ideation and R&D coordination to commercial launch, promotion, and P&L management—ensuring all initiatives address current and emerging clinical oncology needs and align with business objectives. You will lead the development of cutting-edge diagnostic technologies, including advanced NGS-based assays and multiomic platforms, to deliver precise, actionable insights for cancer care and drive improved patient outcomes. The ideal candidate is an entrepreneurial, expert-level leader with hands-on experience in product management of somatic tissue diagnostics (LDTs or IVDs) and a proven ability to implement phase-gated Product Development Processes (PDP) in oncology.
Responsibilities
Salary Range: 250,000- 350,000 USD
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
The Vice President of Product, Oncology – Somatic Tissue Diagnostics, is a visionary executive responsible for setting the strategic direction, execution, and innovation of the company’s somatic tissue diagnostic portfolio. This role oversees the entire product lifecycle—from ideation and R&D coordination to commercial launch, promotion, and P&L management—ensuring all initiatives address current and emerging clinical oncology needs and align with business objectives. You will lead the development of cutting-edge diagnostic technologies, including advanced NGS-based assays and multiomic platforms, to deliver precise, actionable insights for cancer care and drive improved patient outcomes. The ideal candidate is an entrepreneurial, expert-level leader with hands-on experience in product management of somatic tissue diagnostics (LDTs or IVDs) and a proven ability to implement phase-gated Product Development Processes (PDP) in oncology.
Responsibilities
- Strategic Oncology Portfolio Roadmap: Develop and manage a comprehensive product roadmap for the oncology somatic tissue diagnostics portfolio, integrating customer feedback, technology advancements, and clinical oncology trends to address unmet needs in cancer diagnostics.
- Market & Competitive Analysis: Lead in-depth market research and competitive analyses against industry leaders in oncology diagnostics (e.g., Foundation Medicine, Guardant Health, Caris Life Sciences) to identify portfolio gaps, emerging opportunities, and potential differentiators.
- Product Lifecycle Management: Oversee upstream Product Managers in end-to-end lifecycle management for somatic tissue molecular testing services, ensuring successful launches and continuous enhancements of assays and platforms tailored for oncology applications.
- Commercial Strategy Execution: Drive product positioning, messaging, and go-to-market (GTM) strategies for oncology diagnostics by guiding downstream Marketing Managers and collaborating closely with sales, market access, and medical affairs teams to maximize adoption and clinical impact.
- Portfolio P&L Management: Maintain full accountability for the oncology product portfolio P&L, focusing on revenue growth, resource allocation, and measurable business outcomes.
- Stakeholder Engagement: Build strong relationships with key opinion leaders, oncologists, pathologists, and patient advocacy groups to inform product strategy and support clinical adoption.
- Regulatory & Compliance Leadership: Ensure product development and commercialization meet all regulatory requirements for oncology diagnostics, including FDA, CLIA, CAP, and international standards.
- Strategic Market Access & Value Storytelling: Ability to develop and communicate a compelling value proposition that demonstrates the clinical and economic benefits of oncology diagnostics to payers, providers, and health systems. Expertise in navigating complex reimbursement landscapes and designing creative pricing or risk-sharing models for cancer testing.
- Patient-Centric Advocacy & Empathy: Specialized capability to integrate the patient journey and voice into product design and commercial strategy, including engagement with oncology patient advocacy groups to address barriers such as access, cost, and equity.
- Data-Driven Predictive Analytics: Proficiency in leveraging advanced data science and AI models to identify clinical gaps, optimize test utilization, and forecast adoption obstacles in oncology diagnostics.
- Cross-Functional Matrix Leadership: Ability to influence and lead multidisciplinary teams—including R&D, Medical Affairs, Regulatory, and Sales—without direct authority, harmonizing these groups to ensure products remain clinically relevant and commercially successful.
- Agile & Adaptive Decision-Making: High-level ability to make critical, data-informed decisions under pressure in the rapidly evolving oncology diagnostics landscape, including strategic agility to pivot the product roadmap in response to new clinical discoveries or regulatory changes.
- Regulatory & Quality Expertise: Strong understanding of regulatory pathways and quality standards for oncology diagnostics, including FDA submissions, CLIA validation, and CAP accreditation.
- Required Education: Bachelor’s degree in Biology, Genetics, Oncology, or a related scientific field.
- Preferred Education: Advanced degree such as an MBA, PhD, or MD is highly preferred, bridging the gap between complex science, clinical oncology, and business strategy.
- Specialized Knowledge: Deep understanding of oncology, including somatic mutation biology, cancer genomics, clinical workflows, and the evolving landscape of tissue diagnostics.
- Commercial Knowledge: Extensive knowledge of market demands, technology trends, and the regulatory environment for oncology molecular diagnostics.
- Leadership Tenure: Minimum of 10+ years of progressive leadership experience in product management, specifically within oncology diagnostics, molecular pathology, or genetics-based healthcare.
- Portfolio Growth: Proven track record of developing complex portfolio plans and leading successful commercial launches of oncology diagnostic tests at scale in a competitive market.
- Oncology Expertise: Significant experience navigating the unique challenges of the oncology diagnostics market, including specialized billing practices, regulatory pathways, and patient-centric programs.
Salary Range: 250,000- 350,000 USD
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Keep track of your job search
Save personal notes for each job to track your thoughts, application status, and follow-ups.
Try for freeUpload your resume
Sign up to upload your resume and get AI-powered customization for job applications.
Sign up freePractice your interview
Get AI-powered mock interviews tailored to this VP of Product - Oncology – Somatic Tissue role. Upload your resume and practice with real-time voice feedback.
Sign up to practice